Strain Name:

C57BLKS-Rpl24Bst/J

Stock Number:

000516

Order this mouse

Availability:

Research Strain

Belly spot and tail (Rpl24Bst) is a semidominant, homozygous in utero lethal mutation. The mutation has variable expressivity and the heterozygous phenotypic traits include shortened and kinked tail, white feet and belly spot, malocclusion, smaller body size, exencephaly, abnormalities of the spine, ocular defects, and polydactyly. Mutants have underlying optic nerve atrophy; after seven months of age, 19% of heterozygotes have focal, nonrhegmatogenous, retinal detachment accompanied by subretinal neovascularization. This strain offers a model for human optic atrophy and age-related subretinal neovascularization

Description

Strain Information

Former Names C57BLKS-Bst/J    (Changed: 15-DEC-04 )
Type Coisogenic; Mutant Strain; Spontaneous Mutation;
Additional information on Genetically Engineered and Mutant Mice.
Visit our online Nomenclature tutorial.
Specieslaboratory mouse

Appearance
black with belly spot
Related Genotype: a/a Rpl24Bst/+

black
Related Genotype: a/a +/+

Description
Belly spot and tail (Rpl24Bst) is a semidominant, homozygous in utero lethal mutation. Adult heterozygotes are viable and fertile although a reduced birth rate for heterozygotes has been reported. This may reflect incomplete penetrance, or, more likely, prenatal mortality. The Rpl24Bst mutation has variable expressivity and the heterozygous phenotypic traits include shortened and kinked tail, white feet and belly spot, malocclusion, smaller body size, exencephaly, abnormalities of the spine, ocular defects, and polydactyly. Polydactyly is found predominantly in the right rear paw, occasionally in the left front paw and rarely in the left rear or right front paws. Approximately 50-60% of the heterozygotes have a reduction in pupillary light reflex in one or both eyes due to an underlying optic nerve atrophy. Ontological studies showed a delay in the developmental fusion of the optic fissure, a disruption of the retinal layers by embryonic day 15, and smaller optic nerves, and abnormal retinal morphology at postnatal day 0. BrdU labeling revealed a temporary delay of cellular differentiation in the neural retina at embryonic day 10.5. After seven months of age, 19% of heterozygotes have focal, nonrhegmatogenous, retinal detachment accompanied by subretinal neovascularization. Thus, this strain offers a model for human optic atrophy and age-related subretinal neovascularization. (Smith et al., 2000; Tang et al., 1999; Rice et al., 1997; Rice et al., 1995; Harris et al., 1989; Epstein et al., 1986; Southard and Eicher, 1977).

Development
The mutation, Rpl24Bst, occurred In 1976 in strain C57BL/Ks.J. The spontaneous 4bp deletion disrupts the first intron branchpoint and causes abnormal splicing with retention of intron 1. The deletion removes a critical adenosine that reacts to form the lariat intermediate. PCR indicated that this is a hypomorphic allele where heterozygotes have approximately 60% of normal transcript levels and homozygotes have 20%.

Control Information

  Control
   Wild-type from the colony
 
  Considerations for Choosing Controls

Phenotype

Phenotype Information

View Related Disease (OMIM) Terms

Related Disease (OMIM) Terms provided by MGI
- Model with phenotypic similarity to human disease where etiologies are distinct. Human genes are associated with this disease. Orthologs of these genes do not appear in the mouse genotype(s).
Optic Atrophy 1; OPA1
View Mammalian Phenotype Terms

Mammalian Phenotype Terms provided by MGI
      assigned by genotype

Rpl24Bst/Rpl24+

        C57BLKS
  • mortality/aging
  • complete prenatal lethality
    • smaller litter size likely due to in utero death on the C57BLKS background compared with a mixed background of AKR and C57BLKS   (MGI Ref ID J:28035)
  • partial embryonic lethality
    • at embryonic day 11.5 only one quarter to one third of embryos from wild-type x heterozygous matings are mutant   (MGI Ref ID J:53381)
  • pigmentation phenotype
  • white spotting   (MGI Ref ID J:43133)
    • white feet   (MGI Ref ID J:28035)
    • belly spot   (MGI Ref ID J:28035)
      • white belly spot   (MGI Ref ID J:13703)
  • vision/eye phenotype
  • abnormal eye development
    • at birth affected heterozygotes have abnormal neural retina, buckled in severe cases, the optic nerves are smaller than normal and contain fewer axons, and the ganglion cell layer is thinner, with an increase in the number of dying cells   (MGI Ref ID J:43133)
    • abnormal optic cup morphology
      • beginning at embryonic day 10.5 and persisting through embryonic day 13.5 the optic cup is 60 um more shallow than that of wild-type siblings   (MGI Ref ID J:53381)
    • abnormal retinal progenitor cell morphology
      • beginning at embryonic day 11.5 there is a sparsely cellularized layer formed on the vitreal surface of the dorsal retina   (MGI Ref ID J:53381)
      • although the proliferation index is normal and cell death in the neuroal retina is normal, BrdU labeling of embyronic day 10.5 shows that there is a delay in exit from the cell cycle in cells of the developing retina   (MGI Ref ID J:53381)
    • delayed optic fissure closure
      • at embryonic day 12 the development of the optic fissure is delayed   (MGI Ref ID J:43133)
      • delay in the closure of the optic fissure, with less than half of the heterozygous retinas being fused by embryonic day 13.5 when this process is completed in wild-type siblings   (MGI Ref ID J:53381)
    • optic nerve coloboma   (MGI Ref ID J:43133)
      • optic nerve colobomas range from mild loss of nerve fibers on the surface of the optic cup to complete absence of the nerve and severe abnormalities of the peripapillary nerual retina, retinal pigment epithelium, and choroid   (MGI Ref ID J:60921)
    • persistence of hyaloid vascular system
      • large hyaloid vessels are present at up to 22 months of age and come from the optic nerve, not the sensory retina   (MGI Ref ID J:60921)
  • abnormal eye size
    • at embryonic day 10.5 approximately 25% of heterozygotes have size disparities between the eyes   (MGI Ref ID J:53381)
  • abnormal optic nerve morphology
    • variable expressivity in the optic nerve phenotype such that heterozygotes can have optic nerves that are normal, small or missing on one side, or completely absent from both sides   (MGI Ref ID J:43133)
    • absent optic nerve
      • 23 of 28 heterozygotes with diminished pupillary light response lack an optic nerve   (MGI Ref ID J:43133)
    • optic nerve atrophy
      • variable unilateral or bilateral atrophy of the optic nerves   (MGI Ref ID J:28035)
    • optic nerve coloboma   (MGI Ref ID J:43133)
      • optic nerve colobomas range from mild loss of nerve fibers on the surface of the optic cup to complete absence of the nerve and severe abnormalities of the peripapillary nerual retina, retinal pigment epithelium, and choroid   (MGI Ref ID J:60921)
    • optic nerve hypoplasia
      • the optic nerves associated with reduced pupullary light response are smaller than normal, have degenerating fibers, and fewer ganglion cell axons than normal. Despite this, the ipsilateral population of ganglion cells is overrepresented in affected heterozygotes   (MGI Ref ID J:43133)
      • the optic nerves in heterozygotes with normal pupillary light response have fewer axons on average than those of wild-type controls   (MGI Ref ID J:43133)
  • abnormal retina morphology
    • incomplete expressivity in abnormalities of the retinal morphology leaves some heterozygous adults with normal retinas and the severely affected having distorted organization of the neural retina, particularly the optic disc area, with the inner and outer nuclear layers distorted into folds, rosettes, or colobomas   (MGI Ref ID J:43133)
    • after 7 months of age retinal detachment, subretinal macrophages, and subretinal neovascularization are found   (MGI Ref ID J:60921)
    • retinal folds and small patches of retinal thinning are common and in 21% of affected heterozygotes small patches of retinal dysplasia are found close to the optic nerve or in the peripheral retina   (MGI Ref ID J:60921)
    • abnormal retinal layer morphology
      • at embryonic day 12 the layers of the retina are often disrupted   (MGI Ref ID J:43133)
      • abnormal retinal neuronal layer morphology   (MGI Ref ID J:43133)
        • abnormal retinal ganglion layer morphology   (MGI Ref ID J:92052)
          • in the most severely affected heterozygous adults the ganglion cell layer has few cells and these may not be ganglion cells   (MGI Ref ID J:43133)
          • an increase in ectopic ipsilaterally projecting ganglion cells, outside of the ventrotemporal part of the retina, is found in heterozygotes with a small optic nerve   (MGI Ref ID J:43133)
          • decreased retinal ganglion cell number   (MGI Ref ID J:43133)
          • thin retinal ganglion layer   (MGI Ref ID J:43133)
        • abnormal retinal inner plexiform layer morphology
          • reduced in thickness   (MGI Ref ID J:43133)
        • disorganized retinal inner nuclear layer   (MGI Ref ID J:43133)
        • disorganized retinal outer nuclear layer   (MGI Ref ID J:43133)
        • thin retinal inner nuclear layer
          • in the most severely affected heterozygotes   (MGI Ref ID J:43133)
    • abnormal retinal progenitor cell morphology
      • beginning at embryonic day 11.5 there is a sparsely cellularized layer formed on the vitreal surface of the dorsal retina   (MGI Ref ID J:53381)
      • although the proliferation index is normal and cell death in the neuroal retina is normal, BrdU labeling of embyronic day 10.5 shows that there is a delay in exit from the cell cycle in cells of the developing retina   (MGI Ref ID J:53381)
    • retina hypoplasia
      • surface area of the retina is 10% snmaller, on average, in affected heterozygotes   (MGI Ref ID J:43133)
    • retinal detachment
      • localized, posterior pole, nonrhegmatogenous retinal detachment is found and is usually temporal to the optic nerve   (MGI Ref ID J:60921)
      • in some P0 retinas, the neural retina is buckled, resulting in detachment from the pigment epithelium   (MGI Ref ID J:43133)
    • retinal neovascularization
      • subretinal neovascularization with submacular hemorrhage and fibrosis is found and accompanies most instances of retinal degeneration in these heterozygotes   (MGI Ref ID J:60921)
  • cataracts
    • anterior and posterior subcapsular and cortical cataracts are present in a minority of affected heterozygotes   (MGI Ref ID J:60921)
  • impaired pupillary reflex
    • direct pupilary light response is weak or absent in approximately 60% of heterozygotes with a third of these having a bilateral deficit and the remainder only a unilateral deficit   (MGI Ref ID J:43133)
    • detectable as soon as the eyelids open   (MGI Ref ID J:43133)
  • growth/size/body phenotype
  • decreased body weight
    • mutants are 20% smaller than wild-type littermates and this persists into adulthood   (MGI Ref ID J:92052)
  • decreased embryo size
    • at embryonic day 9.5 approximately one third of the embryos from wild-type x heterozygous matings are visiblyh smaller than normal   (MGI Ref ID J:53381)
    • at embryonic day 10.5 approximately 60% of embryos from wild-type x heterozygous matings are normal size and the remainder are either small, defined as <4mm crown to rump length, or diminutive, defined as <3.5mm crown to rump length, with most of the cells in the diminutive embryos being apoptotic according to TUNEL staining   (MGI Ref ID J:53381)
    • at embryonic day 11.5 short tailed embryos are 5.9mm instead of the wild-type 6.3mm   (MGI Ref ID J:53381)
    • at embryonic day 12.5 short tailed embryos are 8.1mm instead of the wild-type 8.9mm   (MGI Ref ID J:53381)
    • at embryonic day 13.5 short tailed embryos are 9.8mm instead of the wild-type 10.6mm   (MGI Ref ID J:53381)
  • limbs/digits/tail phenotype
  • abnormal digit morphology
    • triphalangeal first digit and and extra preaxial digit are often found   (MGI Ref ID J:92052)
    • polydactyly   (MGI Ref ID J:43133)
      • polydactyly affecting one to three feet   (MGI Ref ID J:13703)
      • first seen at embryonic day 13.5, principally on the right rear paw   (MGI Ref ID J:53381)
  • caudal vertebral fusion
    • mutants can have fused or wedge-shaped hemivertebrae at the sites of tail kinks   (MGI Ref ID J:92052)
  • decreased caudal vertebrae number
    • mutants have fewer caudal vertebrae   (MGI Ref ID J:92052)
  • kinked tail   (MGI Ref ID J:13703)
    • kinks found as early as embryonic day 12.5   (MGI Ref ID J:53381)
  • short tail   (MGI Ref ID J:13703)
    • first evident at embryonic day 11.5   (MGI Ref ID J:53381)
  • skeleton phenotype
  • caudal vertebral fusion
    • mutants can have fused or wedge-shaped hemivertebrae at the sites of tail kinks   (MGI Ref ID J:92052)
  • decreased caudal vertebrae number
    • mutants have fewer caudal vertebrae   (MGI Ref ID J:92052)
  • increased lumbar vertebrae number
    • mutants have six lumbar vertebrae instead of the wild-type five   (MGI Ref ID J:92052)
  • nervous system phenotype
  • abnormal optic nerve morphology
    • variable expressivity in the optic nerve phenotype such that heterozygotes can have optic nerves that are normal, small or missing on one side, or completely absent from both sides   (MGI Ref ID J:43133)
    • absent optic nerve
      • 23 of 28 heterozygotes with diminished pupillary light response lack an optic nerve   (MGI Ref ID J:43133)
    • optic nerve atrophy
      • variable unilateral or bilateral atrophy of the optic nerves   (MGI Ref ID J:28035)
    • optic nerve coloboma   (MGI Ref ID J:43133)
      • optic nerve colobomas range from mild loss of nerve fibers on the surface of the optic cup to complete absence of the nerve and severe abnormalities of the peripapillary nerual retina, retinal pigment epithelium, and choroid   (MGI Ref ID J:60921)
    • optic nerve hypoplasia
      • the optic nerves associated with reduced pupullary light response are smaller than normal, have degenerating fibers, and fewer ganglion cell axons than normal. Despite this, the ipsilateral population of ganglion cells is overrepresented in affected heterozygotes   (MGI Ref ID J:43133)
      • the optic nerves in heterozygotes with normal pupillary light response have fewer axons on average than those of wild-type controls   (MGI Ref ID J:43133)
  • decreased retinal ganglion cell number   (MGI Ref ID J:43133)
  • exencephaly
    • in approximately 30% of heterozygotes   (MGI Ref ID J:43133)
    • found by embronic day 11.5   (MGI Ref ID J:53381)
  • behavior/neurological phenotype
  • impaired pupillary reflex
    • direct pupilary light response is weak or absent in approximately 60% of heterozygotes with a third of these having a bilateral deficit and the remainder only a unilateral deficit   (MGI Ref ID J:43133)
    • detectable as soon as the eyelids open   (MGI Ref ID J:43133)
  • cellular phenotype
  • abnormal cell physiology
    • pulse labeling shows impaired ribosome biogenesis, particularly of the 28S rRNA   (MGI Ref ID J:92052)
    • abnormal cell cycle
      • embryonic fibroblast cultures have a slower doubling time, decreased ratio of G1 to S phase, and an increased length of G1 after serum stimulation   (MGI Ref ID J:92052)
  • cardiovascular system phenotype
  • pathological neovascularization   (MGI Ref ID J:60921)
    • retinal neovascularization
      • subretinal neovascularization with submacular hemorrhage and fibrosis is found and accompanies most instances of retinal degeneration in these heterozygotes   (MGI Ref ID J:60921)
  • embryogenesis phenotype
  • decreased embryo size
    • at embryonic day 9.5 approximately one third of the embryos from wild-type x heterozygous matings are visiblyh smaller than normal   (MGI Ref ID J:53381)
    • at embryonic day 10.5 approximately 60% of embryos from wild-type x heterozygous matings are normal size and the remainder are either small, defined as <4mm crown to rump length, or diminutive, defined as <3.5mm crown to rump length, with most of the cells in the diminutive embryos being apoptotic according to TUNEL staining   (MGI Ref ID J:53381)
    • at embryonic day 11.5 short tailed embryos are 5.9mm instead of the wild-type 6.3mm   (MGI Ref ID J:53381)
    • at embryonic day 12.5 short tailed embryos are 8.1mm instead of the wild-type 8.9mm   (MGI Ref ID J:53381)
    • at embryonic day 13.5 short tailed embryos are 9.8mm instead of the wild-type 10.6mm   (MGI Ref ID J:53381)
  • integument phenotype
  • white spotting   (MGI Ref ID J:43133)
    • white feet   (MGI Ref ID J:28035)
    • belly spot   (MGI Ref ID J:28035)
      • white belly spot   (MGI Ref ID J:13703)

Rpl24Bst/Rpl24Bst

        C57BLKS
  • mortality/aging
  • complete embryonic lethality
    • homozygotes die before embryonic day 9.5   (MGI Ref ID J:92052)
View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Rpl24Bst related

Dermatology Research
Color and White Spotting Defects

Developmental Biology Research
Embryonic Lethality (Homozygous)
Eye Defects
Growth Defects
Neurodevelopmental Defects
Skeletal Defects

Neurobiology Research
Neurodevelopmental Defects

Research Tools
Developmental Biology Research
Neurobiology Research

Sensorineural Research
Eye Defects
      autosomal dominant optic atrophy ADOA
Retinal Degeneration

Genes & Alleles

Gene & Allele Information provided by MGI

 
Allele Symbol Rpl24Bst
Allele Name belly spot and tail
Allele Type Spontaneous
Common Name(s) Bst;
Strain of OriginC57BLKS/J
Gene Symbol and Name Rpl24, ribosomal protein L24
Chromosome 16
Gene Common Name(s) 0610008L05Rik; Bst; HEL-S-310; L24; RIKEN cDNA 0610008L05 gene; belly spot and tail;
Molecular Note A 4 bp deletion disrupts the first intron branchpoint and causes abnormal splicing with retention of intron 1. The deletion removes a critical adenosine that reacts to form the lariat intermediate. PCR indicated that this is a hypomorphic allele where heterozygotes have approximately 60% of normal transcript levels and homozygotes have 20%. [MGI Ref ID J:92052]

Genotyping

Genotyping Information


Helpful Links

Genotyping resources and troubleshooting

References

References provided by MGI

Additional References

Aijaz S; Erskine L; Jeffery G; Bhattacharya SS; Votruba M. 2004. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer. Invest Ophthalmol Vis Sci 45(6):1667-73. [PubMed: 15161824]  [MGI Ref ID J:92284]

Delettre C; Lenaers G; Belenguer P; Hamel CP. 2003. Gene structure and chromosomal localization of mouse Opa1 : its exclusion from the Bst locus. BMC Genet 4(1):8. [PubMed: 12735796]  [MGI Ref ID J:83833]

Epstein R; Davisson M; Lehmann K; Akeson EC; Cohn M. 1986. Position of Igl-1, md, and Bst loci on chromosome 16 of the mouse. Immunogenetics 23(2):78-83. [PubMed: 3082752]  [MGI Ref ID J:8234]

Rice DS; Tang Q; Williams RW; Harris BS; Davisson MT; Goldowitz D. 1997. Decreased retinal ganglion cell number and misdirected axon growth associated with fissure defects in Bst/+ mutant mice. Invest Ophthalmol Vis Sci 38(10):2112-24. [PubMed: 9331275]  [MGI Ref ID J:43133]

Rice DS; Williams RW; Ward-Bailey P; Johnson KR; Harris BS; Davisson MT; Goldowitz D. 1995. Mapping the Bst mutation on mouse chromosome 16: a model for human optic atrophy. Mamm Genome 6(8):546-8. [PubMed: 8589526]  [MGI Ref ID J:28035]

Tang Q; Rice DS; Goldowitz D. 1999. Disrupted retinal development in the embryonic belly spot and tail mutant mouse. Dev Biol 207(1):239-55. [PubMed: 10049578]  [MGI Ref ID J:53381]

Rpl24Bst related

Aijaz S; Erskine L; Jeffery G; Bhattacharya SS; Votruba M. 2004. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer. Invest Ophthalmol Vis Sci 45(6):1667-73. [PubMed: 15161824]  [MGI Ref ID J:92284]

Barkic M; Crnomarkovic S; Grabusic K; Bogetic I; Panic L; Tamarut S; Cokaric M; Jeric I; Vidak S; Volarevic S. 2009. The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival. Mol Cell Biol 29(10):2489-504. [PubMed: 19273598]  [MGI Ref ID J:148991]

Barna M; Pusic A; Zollo O; Costa M; Kondrashov N; Rego E; Rao PH; Ruggero D. 2008. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456(7224):971-5. [PubMed: 19011615]  [MGI Ref ID J:142390]

Chang B; Hawes NL; Hurd RE; Wang J; Howell D; Davisson MT; Roderick TH; Nusinowitz S; Heckenlively JR. 2005. Mouse models of ocular diseases. Vis Neurosci 22(5):587-93. [PubMed: 16332269]  [MGI Ref ID J:156373]

Epstein R; Davisson M; Lehmann K; Akeson EC; Cohn M. 1986. Position of Igl-1, md, and Bst loci on chromosome 16 of the mouse. Immunogenetics 23(2):78-83. [PubMed: 3082752]  [MGI Ref ID J:8234]

Hsieh AC; Costa M; Zollo O; Davis C; Feldman ME; Testa JR; Meyuhas O; Shokat KM; Ruggero D. 2010. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell 17(3):249-61. [PubMed: 20227039]  [MGI Ref ID J:158661]

Kondrashov N; Pusic A; Stumpf CR; Shimizu K; Hsieh AC; Xue S; Ishijima J; Shiroishi T; Barna M. 2011. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 145(3):383-97. [PubMed: 21529712]  [MGI Ref ID J:173414]

Oliver ER; Saunders TL; Tarle SA; Glaser T. 2004. Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development 131(16):3907-20. [PubMed: 15289434]  [MGI Ref ID J:92052]

Rice DS; Tang Q; Williams RW; Harris BS; Davisson MT; Goldowitz D. 1997. Decreased retinal ganglion cell number and misdirected axon growth associated with fissure defects in Bst/+ mutant mice. Invest Ophthalmol Vis Sci 38(10):2112-24. [PubMed: 9331275]  [MGI Ref ID J:43133]

Rice DS; Williams RW; Ward-Bailey P; Johnson KR; Harris BS; Davisson MT; Goldowitz D. 1995. Mapping the Bst mutation on mouse chromosome 16: a model for human optic atrophy. Mamm Genome 6(8):546-8. [PubMed: 8589526]  [MGI Ref ID J:28035]

Silvers WK. 1979. The Coat Colors of Mice; A Model for Mammalian Gene Action and Interaction. In: The Coat Colors of Mice. Springer-Verlag, New York.  [MGI Ref ID J:78801]

Smith RS; John SW; Zabeleta A; Davisson MT; Hawes NL; Chang B. 2000. The bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization. Proc Natl Acad Sci U S A 97(5):2191-5. [PubMed: 10681427]  [MGI Ref ID J:60921]

Southard JL; Eicher EM. 1977. Bst. Mouse News Lett 56:40.  [MGI Ref ID J:13703]

Tang Q; Rice DS; Goldowitz D. 1999. Disrupted retinal development in the embryonic belly spot and tail mutant mouse. Dev Biol 207(1):239-55. [PubMed: 10049578]  [MGI Ref ID J:53381]

Health & husbandry

Health & Colony Maintenance Information

Animal Health Reports

Room Number           A1

Pricing and Purchasing

Pricing, Supply Level & Notes, Controls


Pricing for USA, Canada and Mexico shipping destinations View International Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $170.25Female or MaleHeterozygous for Rpl24Bst  
Price per Pair (US dollars $)Pair Genotype
$240.25Heterozygous for Rpl24Bst x Wild-type for Rpl24Bst  
$240.25Wild-type for Rpl24Bst x Heterozygous for Rpl24Bst  

Standard Supply

Research Strain. Availability determined by The Jackson Laboratory scientist holding the strain.

Pricing for International shipping destinations View USA Canada and Mexico Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $221.40Female or MaleHeterozygous for Rpl24Bst  
Price per Pair (US dollars $)Pair Genotype
$312.40Heterozygous for Rpl24Bst x Wild-type for Rpl24Bst  
$312.40Wild-type for Rpl24Bst x Heterozygous for Rpl24Bst  

Standard Supply

Research Strain. Availability determined by The Jackson Laboratory scientist holding the strain.

View USA Canada and Mexico Pricing View International Pricing

Standard Supply

Research Strain. Availability determined by The Jackson Laboratory scientist holding the strain.

General Supply Notes

Control Information

  Control
   Wild-type from the colony
 
  Considerations for Choosing Controls
  Control Pricing Information for Genetically Engineered Mutant Strains.
 

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.


See Terms of Use tab for General Terms and Conditions


The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering Information
JAX® Mice
Surgical and Preconditioning Services
JAX® Services
Customer Services and Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form

Terms of Use

Terms of Use


General Terms and Conditions


Contact information

General inquiries regarding Terms of Use

Contracts Administration

phone:207-288-6470

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCTS" means biological materials supplied by JACKSON, and their derivatives. "RECIPIENT" means each recipient of MICE, PRODUCTS, or services provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than the internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE or PRODUCTS from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON's prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.


(6.5)